Myovant Sciences made four key appointments to its managing team. Matthew Lang, J.D., joined the company as general counsel and corporate secretary; Juan Camilo Arjona Ferreira, M.D., came aboard as chief medical officer; Teresa Perney, Ph.D., was appointed senior VP of Regulatory Affairs and Quality Assurance; and Andria Langenberg, M.D., was tapped as head of Drug Safety and Pharmacovigilance.

Understanding the nuances behind why a physician makes a decision regarding an information source when making a clinical decision is key to learning the best way to deliver content that will prompt an engagement.